Chongqing Dikang Changjiang Pharmaceutical Co., Ltd. was formed by Sichuan Dikang Pharmaceutical Co., Ltd. in August 1998, supporting the merger and reorganization of the former Sichuan Changjiang Pharmaceutical Factory in the Three Gorges reservoir area. It is a flooded relocation enterprise of the Three Gorges Project, a key pharmaceutical enterprise in Chongqing, a high-tech enterprise in Chongqing and a key industrial enterprise in Wanzhou District.
The new factory is located atNo. 1 Dikang Road, Wuqiao, Wanzhou, covering an area of 430 mu, with total assets of185.38 million yuan. The company has 758 employees, including 35 licensed pharmacists, 6 with senior titles and 0/48 with intermediate titles. It has 9 dosage forms, such as tablets, capsules, large-capacity injections, small-capacity injections and chemical synthetic raw materials, and has more than 330 kinds of national essential drugs.
The first-phase project of the company's technical transformation and relocation "Large-capacity injection workshop and supporting project" was completed and put into production on June 2002 1998, and the second-phase project "Small-capacity injection workshop and supporting project" was put into production on June 2002 10, and both workshops have passed the national GMP certification. The comprehensive preparation workshop, complex building, warehouse and auxiliary facilities under construction are scheduled to be completed by the end of September. By then, it will have an annual production capacity of 30 million bottles of infusion,1.200 million water injection, 5 million bottles of powder injection, 700 million tablets and 300 million capsules.
At present, the company has successfully developed and will soon put into production and sell products such as GlaxoSmithKline injection, Shenmai powder injection and antiviral injection. Some of them are national first-class new drugs, and the market capacity of a single variety is large, with annual sales income of over 100 million yuan.
Under the overall planning of the company, in 2007, the output value was 654.38 billion yuan, the sales income was 800 million yuan, the profit was 50 million yuan, and the tax revenue was 20 million yuan, which contributed to the rapid development of Wanzhou's industrial economy.